Hypocomplementemia in Chronic Idiopathic Urticaria

  1. DAVID A. MATHISON, M.D., F.A.C.P.;
  2. CARLOS M. ARROYAVE, M.D.;
  3. K. NARAS BHAT, M.D., F.A.C.P.;
  4. LCDR DAVID S. HUREWITZ; and
  5. DANIEL J. MARNELL
  1. MC, USNR
  2. MC, USNR
  3. La Jolla, California

    Abstract

    A discrete evoking factor or presumed pathophysiologic mechanism is not recognized in the majority of patients with chronic urticaria or angioedema. Two cases are reported in which chronic urticaria was the main manifestation of an immune cutaneous vasculitis associated with hypocomplementemia attributable to classic and alternative mechanisms of complement activation. Among 72 consecutive patients evaluated for chronic urticaria, 10 additional patients with idiopathic urticaria were found to have hypocomplementemia. Of these, two had evidence of classic and alternative mechanisms of complement activation, five had evidence of only classic pathway activation, and three evidence of predominately or exclusively alternative pathway activation. Circulating immune complexes were found in the majority of patients with classic pathway activation. Hypocomplementemia may provide clues to pathophysiologic mechanisms operative in some patients with chronic urticaria.

    Article and Author Information

    • ▸From the Division of Allergy and Immunology, Scripps Clinic and Research Foundation; La Jolla, California; and the Allergy and Dermatology Clinics, Naval Regional Medical Center; San Diego, California.

    • ▸Requests for reprints should be addressed to David A. Mathison, M.D.; 10666 North Torrey Pines Road; La Jolla, CA 92037.

      • Received November 15, 1976.
      • Accepted February 9, 1977.
    « Previous | Next Article »Table of Contents